← All trials
NCT01188824
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2010
- Primary completion
- Jul 1, 2013
- Completion date
- Jul 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 801
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- China Medical UniversityLead sponsor
- En Chu Kong HospitalCollaborator
- Shin Kong Wu Ho-Su Memorial HospitalCollaborator
- Far Eastern Memorial HospitalCollaborator
- Changhua Christian HospitalCollaborator
- Cathay General HospitalCollaborator
- Kuang Tien General HospitalCollaborator
- Chung Shan Medical UniversityCollaborator
- National Taiwan UniversityCollaborator
- I-Shou UniversityCollaborator
- Government of TaiwanCollaborator
- Kaohsiung Medical UniversityCollaborator
- National Cheng Kung UniversityCollaborator
- Chimei Medical CenterCollaborator
- China Medical UniversityOverall official - principal investigator
- Taipei Veteran General hospitalCollaborator
- Mackay Medical CollegeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.